The Latin America, Middle East and Africa Pharmaceutical Gelatin Market would witness market growth of 8.4 % CAGR during the forecast period (2022-2028).
Presently, natural origin-based safe materials are in high demand across the world. Thus, the requirement for a boost in advancements for patient safety is rising. Gelatin fulfills those demands. Gelatin is a naturally occurring protein that is obtained from animal collagen. It is non-allergenic. Also, it has been Generally Recognized as Safe (GARS) to use by FDA.
Gelatin has exceptional physical and chemical properties. In the manufacturing process of gelatin, the pharmaceutical industry is required to stick to the strict national and international pharmaceutical processing regulations. In medical innovation, the gelatin will continue to remain an essential part. Developments and exploration, particularly in the domain of regenerative medicine, where experiments on cell growth and repairing of body organs are being experimented, are still going on, holding a huge number of opportunities for the future.
Pig skin is the commonly used raw material in making gelatin due to its high collagen content. The product obtained from pig skin is common acts as a thickener, stabilizer, texturizer, and binder and also used in producing capsules. The porcine gelatin segment is in high demand by the food & beverage industry that uses porcine gelatin for making nutritional and sports products. Usage of bovine hide-based products will also surge in the upcoming years due to the significant amount of protein content in them and also their quality to absorb water easily.
Under the Tanzanian government’s Vision 2030, they plan to invest around $65 billion to develop the country’s healthcare infrastructure. Furthermore, to promote preventive and integrated care and enhance the accessibility to health services, the Ministry of Healthcare plans to initiate a health cluster across Tanzania. Hence, the increasing healthcare funding & infrastructure, the demand for gelatin-based medications will also surge, expanding the market for pharmaceutical gelatin in the LAMEA region.
The Brazil market dominated the LAMEA Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $31.3 million by 2028. The Argentina market is showcasing a CAGR of 9% during (2022 - 2028). Additionally, The Egypt market would register a CAGR of 7.5% during (2022 - 2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into Brazil, Argentina, Egypt, Tanzania, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Pharmaceutical Gelatin Market is Predict to reach $1.6 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
By Type
By Source
By Function
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
